CRMD Q2 2017 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$136,168+724.7% YoY

Gross Profit

$118,11686.7% margin

Operating Income

-$7M-5157.3% margin

Net Income

-$5M-3779.3% margin

EPS (Diluted)

$-0.49

QoQ Revenue Growth

+244.2%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$397,620

Balance Sheet

Total Assets

$21M

Total Liabilities

$6M

Stockholders' Equity

$15M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$136,168	$16,511	+724.7%
Gross Profit	$118,116	-$170,681	+169.2%
Operating Income	-$7M	-$5M	-43.0%
Net Income	-$5M	-$5M	-5.3%